Literature DB >> 12050213

A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.

Songya Pang1, Weihua Wang, Barry Rich, Raphael David, Ying Tai Chang, Goldy Carbunaru, Susan E Myers, A Forbes Howie, Karen J Smillie, J Ian Mason.   

Abstract

We investigated two novel point mutations in the human type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing a mild and a severe form of 3beta-HSD deficiency congenital adrenal hyperplasia. The first is a nonstop mutation in the normal stop codon 373 of the gene in exon IV [TGA (Stop) --> TGC (Cys) = Stop373C) identified from one allele of a female child with premature pubarche whose second allele had an E142K mutation. The Stop373C mutation predictably results in an open reading frame and a mutant-type (MT) II 3beta-HSD protein containing 467 amino acid residues, compared with the 372 amino acid residues of wild-type (WT) protein. The second is a homozygous missense mutation in codon 222 [CCA (Pro) --> ACT (Thr) = P222T] in the gene identified from a female neonate with salt-wasting disorder. The pcDNA vectors containing the constructs of WT II 3beta-HSD cDNA, WT cDNA with the open reading frame (WT cDNA(+)), MT Stop373C with the open reading frame (Stop373C(+)) and MT P222T cDNA were transfected in COS-I and 293T cells and expressed a similar amount of 3beta-HSD mRNA. The enzyme activity in intact cells using pregnenolone and dehydroepiandrosterone as substrate in the medium (1 micromol/liter) was identical between the WT cDNA and the WT cDNA(+), but was decreased to 27% of the WT enzymes at 6 h by MT Stop373C(+) enzyme, and was undetectable by P222T enzyme. In the homogenates of the cells, both MT Stop373C(+) and P222T enzyme activities and enzymes were undetectable despite clear detection of WT enzyme activities and WT enzymes. LH response to an LHRH analog stimulation in the pubertal female with the Stop373C/E142K genotypes and in a pubertal female with compound 273/318 frameshift genotypes were comparable to and higher than control females, respectively. In conclusion, a structurally lengthy MT II 3beta-HSD enzyme due to a nonstop mutation was relatively detrimental in intact cells causing the nonclassic phenotype of 3beta-HSD deficiency. A missense P222T mutation was seriously detrimental, causing the classic phenotype of 3beta-HSD deficiency. The undetectable Stop373C and P222T enzymes on Western blottings, together with the respective in vivo and in vitro data, suggest that a relative instability of Stop373C enzyme and a profound instability of the P222T enzyme are likely the detrimental molecular mechanisms. The increased LH in the female with the frameshift genotype and the appropriate LH response in the female with the nonstop genotype correlated with predictably severe and mild ovarian type II 3beta-HSD deficiency, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050213     DOI: 10.1210/jcem.87.6.8559

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  High 17-hydroxyprogesterone level in newborn screening test for congenital adrenal hyperplasia.

Authors:  Yael Levy-Shraga; Orit Pinhas-Hamiel
Journal:  BMJ Case Rep       Date:  2016-02-24

2.  Hereditary sensory and autonomic neuropathy II due to novel mutation in the HSN2 gene in Mexican families.

Authors:  G Pacheco-Cuellar; L M González-Huerta; J M Valdés-Miranda; H Peláez-González; S Zenteno-Bacheron; J Cazarin-Barrientos; S A Cuevas-Covarrubias
Journal:  J Neurol       Date:  2011-04-06       Impact factor: 4.849

3.  A meta-analysis of single base-pair substitutions in translational termination codons ('nonstop' mutations) that cause human inherited disease.

Authors:  Stephen E Hamby; Nick S T Thomas; David N Cooper; Nadia Chuzhanova
Journal:  Hum Genomics       Date:  2011-05       Impact factor: 4.639

4.  Biallelic in-frame deletion in TRAPPC4 in a family with developmental delay and cerebellar atrophy.

Authors:  Ahmed K Saad; Dana Marafi; Tadahiro Mitani; Angad Jolly; Haowei Du; Hasnaa M Elbendary; Shalini N Jhangiani; Zeynep C Akdemir; Richard A Gibbs; Jill V Hunter; Claudia M B C Carvalho; Davut Pehlivan; Jennifer E Posey; Maha S Zaki; James R Lupski
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

5.  Rkr1/Ltn1 Ubiquitin Ligase-mediated Degradation of Translationally Stalled Endoplasmic Reticulum Proteins.

Authors:  Justin J Crowder; Marco Geigges; Ryan T Gibson; Eric S Fults; Bryce W Buchanan; Nadine Sachs; Andrea Schink; Stefan G Kreft; Eric M Rubenstein
Journal:  J Biol Chem       Date:  2015-06-08       Impact factor: 5.157

6.  Translational read-through promotes aggregation and shapes stop codon identity.

Authors:  Lior Kramarski; Eyal Arbely
Journal:  Nucleic Acids Res       Date:  2020-04-17       Impact factor: 16.971

7.  A novel, non-stop mutation in FOXE3 causes an autosomal dominant form of variable anterior segment dysgenesis including Peters anomaly.

Authors:  Lance Doucette; Jane Green; Bridget Fernandez; Gordon J Johnson; Patrick Parfrey; Terry-Lynn Young
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

Review 8.  Degradation of mRNAs that lack a stop codon: a decade of nonstop progress.

Authors:  A Alejandra Klauer; Ambro van Hoof
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-06-27       Impact factor: 9.957

9.  Net -1 frameshifting on a noncanonical sequence in a herpes simplex virus drug-resistant mutant is stimulated by nonstop mRNA.

Authors:  Dongli Pan; Donald M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

10.  Degradation of Stop Codon Read-through Mutant Proteins via the Ubiquitin-Proteasome System Causes Hereditary Disorders.

Authors:  Norihito Shibata; Nobumichi Ohoka; Yusuke Sugaki; Chiaki Onodera; Mizuho Inoue; Yoshiyuki Sakuraba; Daisuke Takakura; Noritaka Hashii; Nana Kawasaki; Yoichi Gondo; Mikihiko Naito
Journal:  J Biol Chem       Date:  2015-10-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.